LONDON (AP) — Britain-based drugmaker GlaxoSmithKline has reported a drop in earnings in the first full quarter since its deal to swap some assets with Swiss rival Novartis.
Search Results - stltoday.com, St. Louis Post-Dispatch: Business
Wed, 07/29/2015 - 5:29am